Labcorp Holdings Inc. (LH) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Diagnostics & Research industria. La empresa tiene su sede en Burlington, NC, United States. El CEO actual es Adam H. Schechter.
LH tiene fecha de IPO 1990-03-29, 60,900 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $22.29B.
Labcorp Holdings Inc. is a global life sciences company that provides diagnostic testing and drug development services to support healthcare decision-making for doctors, hospitals, pharmaceutical companies, researchers, and patients. Operating through two main segments—Labcorp Diagnostics and Labcorp Drug Development—the company offers a comprehensive range of laboratory tests including blood chemistry, urinalysis, genetic testing, specialty diagnostics for diseases such as cancer and cardiovascular conditions, and occupational health services. Beyond diagnostics, Labcorp provides end-to-end drug development solutions, medical device testing, and companion diagnostic services from early-stage research through commercial market access. The company serves a diverse clientele including managed care organizations, pharmaceutical and biotechnology companies, hospitals, employers, and individual patients through both traditional laboratory services and digital platforms. Labcorp is committed to advancing clinical trial diversity and improving healthcare access across multiple patient populations.
